Edythe London wins Lectureship Award for Mentorship and Research Contributions
Edythe D. London, professor of psychiatry and molecular and medical pharmacology in the Semel Institute for Neuroscience and Human Behavior and the Geffen School of Medicine, has been presented the Marian W. Fischman Memorial Lectureship by the College on Problems of Drug Dependence, the longest standing group in the United States addressing problems of drug dependence and abuse. The award acknowledges London's mentorship to young investigators, and her many and varied research contributions in the field of substance abuse and drug addiction.
The award was presented at the College's 2008 annual meeting in Puerto Rico. London is an internationally recognized expert in the use of neuroimaging to study neural circuitry underlying drug craving. Complementing her commitment to scientific research and education, London has mentored graduate students, postdoctoral fellows and junior faculty interested in the multi-faceted problems of substance abuse and drug addiction. Many of her students have gone on to prestigious positions in academia and government. Additionally, she is a vocal advocate for junior faculty, providing advice, assistance and training opportunities as young investigators strive to become both productive and independent.
The Marian W. Fischman Memorial Lectureship Award was established in honor of Dr. Marian Weinbaum Fischman, a mentor to a generation of young investigators interested in the field of drug abuse. The Semel Institute for Neuroscience and Human Behavior is an interdisciplinary research and education institute devoted to the understanding of complex human behavior, including the genetic, biological, behavioral and sociocultural underpinnings of normal behavior, and the causes and consequences of neuropsychiatric disorders. In addition to conducting fundamental research, the institute faculty seeks to develop effective treatments for neurological and psychiatric disorders, improve access to mental health services, and shape national health policy regarding neuropsychiatric disorders.
Media Contact: Mark Wheeler, 310-794-2265; [email protected]